KAOHSIUNG, May 19, 2024 /PRNewswire/ — The advanced laser and plasma solution provider from Taiwan, E&R Engineering Corp., is confirmed to attend the feast in Semiconductor industry, Semicon SEA 2024, held in Kuala Lumpur, Malaysia. With the 30-year dedication in the semiconductor…
Month: May 2024
KAOHSIUNG, 20 de mayo de 2024 /PRNewswire/ — Se confirma que el proveedor avanzado de soluciones de plasma y láser de Taiwán, E&R Engineering Corp., asistirá a la fiesta de la industria de semiconductores, Semicon SEA 2024, celebrada en Kuala Lumpur, Malasia. Con 30 años de dedicación a…
KAOHSIUNG, 20 mai 2024 /PRNewswire/ — Le fournisseur taïwanais de solutions laser et plasma de pointe, E&R Engineering Corp., a confirmé sa participation au rendez-vous de l’industrie des semi-conducteurs, le salon Semicon SEA 2024, qui se tiendra à Kuala Lumpur, en Malaisie. Avec ses 30…
KAOHSIUNG, May 20, 2024 /PRNewswire/ — The advanced laser and plasma solution provider from Taiwan, E&R Engineering Corp., is confirmed to attend the feast in Semiconductor industry, Semicon SEA 2024, held in Kuala Lumpur, Malaysia. With the 30-year dedication in the semiconductor…
KAOHSIUNG, 20. Mai 2024 /PRNewswire/ — Der fortschrittliche Anbieter von Laser- und Plasmalösungen aus Taiwan, E&R Engineering Corp., hat seine Teilnahme an der Semicon SEA 2024, dem Fest der Halbleiterindustrie, in Kuala Lumpur, Malaysia, bestätigt. Mit seinem 30-jährigen Engagement in…
RADNOR, Pa., May 19, 2024 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. (NYSE: AGL) (“agilon” or the “Company”). This action, captioned Hope v. agilon health,…
Video content, b-roll and images are available here. Tickets on sale now via vividsydney.com SYDNEY, May 19, 2024 /PRNewswire/ — Train travel will never be the same again: in an Australian first, Vivid Sydney today announced Tekno Train by Paul Mac, a one-of-a-kind event that will…
Late-Breaking Results From the Phase 2a COURSE Trial Illustrate Tezspire’s Impact on COPD Exacerbations in Patients With a Broad Range of Eosinophil Levels THOUSAND OAKS, Calif., May 19, 2024 /PRNewswire/ — Amgen (NASDAQ:AMGN) and AstraZeneca today announced the results of the Phase 2a…